JPRN-UMIN000032386已完成未知
Treatment with standard chemotherapy and dendritic cells pulsed with WT1 peptides for pancreatic cancer - Chemotherapy with WT1-DC
The Jikei University School of Medicine, Kashiwa Hospital, Division of Gastroenterology & Hepatology, Department of Internal Medicine0 个研究点目标入组 10 人开始时间: 2018年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) pregnancy 2) serious infections 3) severe underlying disease 4) severe allergic disease 5) a judgment of unsuitability by the principal investigator etc
研究者
相似试验
招募中
1 期
eoantigen based chemoimmunotherapyadvanced pancreatic cancerpancreatic cancer, neoantigen, dendritic cell, cancer vaccinesJPRN-jRCTc030190081Koido Shigeo10
进行中（未招募）
1 期
WT1 based chemoimmunotherapyJPRN-jRCTc030190195Koido Shigeo10
进行中（未招募）
不适用
Treatment With Chemotherapy and Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)Diffuse Large B Cell Lymphoma and HIV InfectionEUCTR2006-003750-23-ESFundación PETHEMA
已完成
1 期
A phase I trial of combination chemotherapy with docetaxel and 5-fluorouracil (DF) for advanced esophagogastric carcinoma (KDOG 0902 P1)advanced or recurrent esophagogastric carcinomaJPRN-UMIN000002041Kitasato University School of Medicine20
已完成
不适用
Reduced intensity chemotherapy given with and without imatinib mesylate in patients >/= 60 years considered unfit for standard chemotherapy with previously untreated acute myeloid leukemia (AML) and refractory anemia with excess of blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T): a randomized phase II studyAcute myeloid leukemia (AML)LeukemiaCancerISRCTN70542454Dutch Haemato-oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON)60